1 / 20

Tuomas Kiviniemi, MD, PhD Turku University Hospital Finland

TIDES-OCT: Randomised multicenter trial comparing Optimax titanium-nitride-oxide coated stent versus Promus-Element stent. Tuomas Kiviniemi, MD, PhD Turku University Hospital Finland. Potential conflicts of interest. Speaker's name: Tuomas Kiviniemi

venedict
Download Presentation

Tuomas Kiviniemi, MD, PhD Turku University Hospital Finland

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. TIDES-OCT:Randomised multicenter trial comparingOptimaxtitanium-nitride-oxide coated stent versusPromus-Elementstent Tuomas Kiviniemi, MD, PhD Turku University Hospital Finland

  2. Potential conflicts of interest Speaker's name: Tuomas Kiviniemi  I have the following potential conflicts of interest to report: Institutional grant/research support: ASTRAZENECA

  3. Background Rapid vascular healing after PCI could enable shorter dual antiplatelet therapy in patients at high risk for bleeding complications

  4. Background • Recent data suggests a paradigm shift in the occurrence of stent thrombosis (ST) • Rate of early and late ST in PtCr-EES < BMS • Uncovered struts and chronic inflammation identified as a nidus for thrombosis Palmerini et al, Lancet 2012

  5. Stent thrombosis with BAS? BASE-ACS, EuroIntervention 2012

  6. New Co-Cr Alloy Platform Stainless Steel Stent Platform Cobalt Chromium Stent Platform • 20% THINNER STRUTS (75 microns) BVS Optimax 75 81 Optimax 0.0030’’ 156 Stefanini G G et al. Heart doi:10.1136/heartjnl-2012-303522

  7. TIDES-OCT study 40 Patients with Acute coronary syndrome (ACS) Randomisation 1:1 OCT and CFR/FFR at 2 months OPTIMAX-BAS Titanium-Nitride-Oxide coated Bio Active Stent (n = 21) PROMUS-Element-EES Everolimus Eluting Stent (n = 19) Academic, investigator driven trial in 4 Finnish PCI centers

  8. Optical Coherence Tomography (OCT) OCT Examination - C7xr Cardiology Imaging System (LightLab Imaging inc, Westford, MA, USA) - A motorized pull-back system at 20 mm/s was used  54.0 mm / 2.7 sec - 6 Fr guiding catheter - During image acquisition, contrast media was infused at 3-6 ml/s - Images were stored digitally for subsequent analysis OCTC7xrTM(St.Jude Medical)

  9. OCT Analysis Strut Level Analysis: Cross-sectional OCT images were analyzed at 1-mm interval (every 5 frames) 1. Neointimal hyperplasia (NIH) thickness, µm - Distance between the vessel wall to the endo-luminal surface of the strut - NIH thickness inside every strut was measured 2. Binary Strut Coverage (%) Number of strut sections covered Total number of strut sections examined x 100

  10. OCT Analysis 3. Apposition (%) A) Apposed and covered B) Apposed and uncovered C) Malapposed and covered D) Malapposed and uncovered E) Strut within the side branch

  11. OCT Analysis 3. Apposition (%) A) Apposed and covered B) Apposed and uncovered C) Malapposed and covered D) Malapposed and uncovered E) Strut within the side branch

  12. Coronary flow reserveRationale: • - The cutpoint value for normal CFR is 2.0 • If CFR is < 2.0 • with no epicardial stenosis or ISR • IMR normal and no diabetes (microvascular dysfunction) •  Endothelial dysfunction? •  Delayed vascular healing after stenting? We sought to examine vascular healing after OPTIMAX- BAS and PROMUS-Element-EES implantation with combining data from OCT and CFR measurements

  13. Invasive CFR, FFR and IMR Thermodilution-derived CFR I.v. adenosine infusion * Invasive measurements were performed using PressureWire Certus in the index vessel. * Thermodilution-derived CFR and IMR measurements were carried on during adenosine infusion

  14. Baseline Demographics * 2/21 patients had OCT follow-up later than 5 months after index PCI and were excluded from the analysis

  15. Procedural Characteristics

  16. TIDES-OCT at 2 monthsFollow-Up Measurement * Stent level analysis

  17. TIDES-OCT at 2 monthsFollow-Up Measurement p < 0.001 % OPTIMAX vs. PROMUS-Element Cross sections with uncovered struts: 8.6% vs. 54.0% (p<0.001) Cross sections with malapposed struts: 3.7% vs. 9.3% (p<0.001) 625 cross-sections / 6872 struts

  18. Uncovered struts with DES 2-3 months % 3.9% - 14% 6.2% - 8.9% 4.7% - 9% * REMEDEE-OCT trial ^ Hatrick-OCT trial ” Kim et al.

  19. Coronary vasodilator function Coronary Flow Reserve (CFR) Delayed vascular Healing?

  20. Take home message • Newer generation BAS shows good coverage and functional healing response at 2 months FU

More Related